You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Volume Charge Distribution Measurement in Thin Dielectrics
SBC: BOX ELDER INNOVATIONS LLC Topic: AF11BT20ABSTRACT: Over half of spacecraft system anomalies attributed to interactions with the natural space environmentincluding electron upsets, damage to components, power system debilities, and complete satellite failuresare attributed to spacecraft charging. While measurements of electron emission, surface potential and electrostatic breakdown provide important information, the"holy grail"of materi ...
STTR Phase I 2012 Department of DefenseAir Force -
The Memory Care Navigator: A Proactive Guide
SBC: Proactive Memory Services Topic: NIADESCRIPTION (provided by applicant): Alzheimer's disease (AD) is an irreversible neurological disease that progressively causes a tremendous toll in disability and societal cost. As our population ages, AD and other memory disorders will become increasingly prevalent. Patients and their families often find themselves lost in a complex web of multiple providers, receiving conflicting recommend ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
SBC: THERATARGET, INC. Topic: NCIDESCRIPTION (provided by applicant): This Phase I proposal addresses the significant need for improved treatment options for patients with liver cancer, the fifth highest incidence of cance in the world. Because of the lack of symptoms, hepatocellular carcinoma (HCC) is detected at advanced stages in 84% of cases, for which the 1-year survival rate is 22% and at 5 years it is 5%. The only curativ ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
Hepatitis C Virus RNA-Targeted Therapeutics
SBC: VIOGEN BIOSCIENCES, LLC Topic: NIAIDDESCRIPTION (provided by applicant): Hepatitis C virus (HCV) infection is a significant human health issue, accounting for 50% of liver transplants in the US, with approximately 170 million persons infected worldwide. The current standard of care therapy of PEGylated-interferon and ribavirin is effective in only about 50% of patients, with severe side effects and contraindications limiting patient ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Selective activation of the vagus nerve as an improved therapy for heart failure
SBC: BLACKROCK MICROSYSTEMS, INC Topic: NHLBIDESCRIPTION (provided by applicant): The goal of the proposed project is to alleviate the enormous public health burden of heart failure. Heart failure leads to significant morbidity and mortality, affects almost five million Americans, and results in morethan 35 billion dollars in annual healthcare costs. Current pharmacological and surgical treatments are only moderately effective and can have s ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
An MPM-based Multiscale Framework for Simulations of Mesoscale Heterogeneous PBXs
SBC: WASATCH MOLECULAR, INC. Topic: AF15AT28ABSTRACT: We will develop a multiscale molecular dynamics/material point method (MD/MPM) methodology for determining the response of PBXs to a wide range of loading conditions as a function of mesoscale structure with emphasis on accurate representation of interfacial physics. The initial material of choice will be HMX + DOA plasticized HTPB binder. Velocity-dependent grain-grain and viscoelastic ...
STTR Phase I 2015 Department of DefenseAir Force -
Biomimetic Material Solutions for the Stabilization of Labile Reagents
SBC: Technology Holding, LLC Topic: AF15AT29ABSTRACT: Elimination of the cold chain is of vital importance for the ability to treat injured warfighters in the field and behind enemy lines. The application of an already FDA approved reagent for the stabilization of labile reagents will allow for minimal development time delaying the fielding of a new technology to fill this role. Collagen has been used extensively since the 1980s as an appro ...
STTR Phase I 2015 Department of DefenseAir Force -
Rapid Monitoring and Assessment of Tubercuolosis Treatment at the Point of Care Using Breath
SBC: NanoSynth Materials and Sensors Inc. Topic: NHLBIDESCRIPTION provided by applicant Problem and Significance According to the CDC global statistics nearly of the world is infected with Tuberculosis TB In million f peopled infected lived in what is considered a high burden country Countries such as India Peru China sub Saharan Africa and others have significant regions endemic for TB particularly among the lower income ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer
SBC: THERATARGET, INC. Topic: NCIDESCRIPTION provided by applicant The purpose of this Phase II STTR project is to develop a polymeric system for the combination delivery of two antineoplastic agents gemcitabine and paclitaxel Based on the successful results of the STTR Phase I award this Phase II proposal details the rationale and research plan for the synthesis and evaluation of in vivo efficacy of two novel macromolecula ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms
SBC: THERATARGET, INC. Topic: 106NARRATIVE This STTR Phase I proposal details the rationale and the research plan for the development of a novel liquid embolizing agent composed of the genetically engineered protein polymerSELPsilk elastinlike proteinKto embolize cerebral aneurysmsThe SELP embolic would reduce the risk of aneurysm rupture while minimizing the risk of recanalization after treatment and providing a platform for del ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health